IPO City Therapeutics Debuts Up 28%: Anatomy of a Successful 2026 Nasdaq Listing
City Therapeutics raised $200 million at $18 a share and opened at $23 on October 16, 2026. Andy Altahawi breaks down the deal structure and the lessons for companies planning their own listing.
